Major depressive disorder, recurrent episode Completed Phase 3 Trials for Sertraline (DB01104)

Back to Major depressive disorder, recurrent episode

Also known as: Depression, Treatment Resistant / Treatment-resistant Depression (TRD) / Resistant Depression, Treatment / Treatment-Resistant Depression / Treatment Resistant Depression (TRD) / Treatment Resistant Depression / Major depressive disorder, recurrent, unspecified / Recurrent major depressive episodes (disorder) / Major depressive disorder, recurrent / Recurrent major depression (disorder) / Treatment resistant depression (disorder) / Depressive Disorder, Treatment-Resistant / Major depressive disorder, single episode, unspecified / Major depressive disorder / Major depressive illness / Major depressive disorder (disorder) / Major depression / Major depressive disorder NOS / Depressive Disorder, Major / Depressive state / Depression NOS / Depressed state / Depression / Depression mental

IndicationStatusPhase
DBCOND0089536 (Major depressive disorder, recurrent episode)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02497287
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionTreatment
NCT02417064
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionTreatment
NCT02418585
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionTreatment